Suven Pharmaceuticals (BOM:543064) Total Stockholders Equity : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals Total Stockholders Equity?

Suven Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Suven Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was ₹N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Suven Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2024 was .

Suven Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Suven Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals Total Stockholders Equity Chart

Suven Pharmaceuticals Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

8,447.63

11,808.08

15,271.80

17,351.84

20,506.63

Suven Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															-	20,506.63	-	19,783.40	-

Suven Pharmaceuticals (BOM:543064) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Suven Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0	-	0)	/	254.565
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Suven Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=

Suven Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Suven Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

SUVENPHAR:India

Address

No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, TG, IND, 500081

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Suven Pharmaceuticals Headlines

No Headlines